Publications by authors named "D H Ryan"

Claim this Profile
O
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial.
Deborah B Horn, Donna H Ryan, Sanja Giljanovic Kis, Breno Alves, Yiming Mu

Lancet· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing the match between patient needs and primary care services: Patient and healthcare provider perspectives from two Canadian provinces.
Emilie Dufour, Maria Mathews, Emily Gard Marshall, Mylaine Breton, Jennifer E Isenor, Dana Ryan

J Health Serv Res Policy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.
Bernardo Sousa-Pinto, Jean Bousquet, Rafael José Vieira, Holger J Schünemann, Torsten Zuberbier, Dermot Ryan

Allergy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Monthly Maridebart Cafraglutide in Obesity - A Phase 2 Trial. Reply.
Ania M Jastreboff, Donna H Ryan, Nicola Pannacciulli

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory disease in pregnancy.
C Murphy, D M Ryan, T Drew

BJA Educ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis